Jacobson Pharma Corporation Limited (SEHK: 2633)
Health Care · Pharmaceuticals · HK
HK$1.05
+1.94% today · -30.5% 1Y
Jacobson Pharma Corporation Limited (SEHK: 2633) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $267.88M and employs 1,768 people.
Over the last twelve months the share price has lost 30.5%, trading between 0.98 and 1.56.
Tweenvest scores Jacobson Pharma Corporation Limited across four factors: quality 82/100, value 64/100, growth 33/100, dividend 91/100. Its strongest factor is dividend.
2633 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $267.88M
- Revenue (TTM)
- $200.19M
- P/E
- 6.95
- EPS
- 0.15
- Dividend yield
- 8.74%
- Beta (5Y)
- 0.22
- 52-week high
- HK$1.56
- 52-week low
- HK$0.98
- Avg volume (3M)
- —
- Shares outstanding
- 2.00B
- Employees
- 1,768
- Next earnings
- —
About Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited, a subsidiary of Kingshill Development Limited, specializes in the production, promotion, and distribution of generic medications and branded healthcare products. Its market reach extends across Hong Kong, mainland China, Macau, Singapore, and international territories. The company offers a broad selection of generic pharmaceuticals targeting diverse medical conditions, including respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergic, scar treatment, oral anti-diabetic, and anti-infective categories. Specific examples comprise arsenic trioxide oral solutions, rosuvastatin tablets, and atorvastatin tablets. In addition to generics, the company provides branded medications, health and wellness products, and traditional Chinese remedies. Prominent proprietary Chinese medicines include Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling oil, Contractubex, Doan's Ointment, and Col-gan tablets. Its operations also extend to trading medical provisions, procuring packaging materials, distributing herbal and health-related goods, conducting research and development, and managing property holdings. The company distributes its offerings to a wide range of clients, including hospitals, clinics, authorized pharmacies, independent physicians, retail outlets, and trading companies. Founded in 2016, Jacobson Pharma Corporation Limited is headquartered in Kwun Tong, Hong Kong.
- ISIN
- KYG677291067
- Founded
- 2016
- Listed since
- Sep 21, 2016
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.